Calamos Advisors’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,794
| Closed | -$257K | – | 916 |
|
|
2025
Q1 | $257K | Sell |
6,794
-3,201
| -32% | -$121K | ﹤0.01% | 739 |
|
|
2024
Q4 | $818K | Sell |
9,995
-16,836
| -63% | -$1.38M | ﹤0.01% | 658 |
|
|
2024
Q3 | $3.07M | Buy |
26,831
+15,298
| +133% | +$1.75M | 0.01% | 545 |
|
|
2024
Q2 | $871K | Buy |
11,533
+1,368
| +13% | +$103K | ﹤0.01% | 631 |
|
|
2024
Q1 | $694K | Buy |
+10,165
| New | +$694K | ﹤0.01% | 659 |
|